A phase II evaluation of tamoxifen, premarin, methotrexate (MTX) and 5-fluorouracil (5-FU) in stage IV breast cancer

J. C. Allegra, T. M. Woodcock, Stephen P Richman

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II evaluation of tamoxifen, premarin, methotrexate (MTX) and 5-fluorouracil (5-FU) in stage IV breast cancer'. Together they form a unique fingerprint.